Registration successful
Account activated – pending validation.
Your account has been activated successfully, but we still need to validate you as a healthcare professional. We’ll send you an email with the result of the validation process in the next three days.
In the meantime, you can enjoy access to all the latest news, events and resources for different therapy areas on our website.
589 results
SK bioscience and GSK start Phase 3 trial of adjuvanted COVID-19 vaccine candidate
31-08-2021
Advance to Phase 3 follows positive interim Phase 1/2 immunogenicity and safety data
GSK receives FDA accelerated approval for JEMPERLI (dostarlimab-gxly) for adult patients with mismatch repair-deficient (dMMR) recurrent or advanced solid tumours
17-08-2021
GARNET study demonstrated objective response rate of 41.6% across dMMR solid tumours
Second-Generation mRNA COVID-19 Vaccine Candidate, CV2CoV, Demonstrates Improved Immune Response and Protection in Preclinical Study
16-08-2021
Preclinical study provides evidence for strongly improved immune responses with second-generation mRNA backbone
GSK and Alector announce global collaboration in immuno-neurology for two clinical stage first-in-class monoclonal antibodies for neurodegenerative diseases
02-07-2021
GSK and Alector to co-develop progranulin-elevating monoclonal antibodies, AL001 and AL101, for a range of neurodegenerative diseases
Elliott Advisors (UK) letter to GSK
02-07-2021
The Board of GSK notes the letter issued by Elliott Advisors (UK) Limited (“Elliott”) on 1 July
New GSK to deliver step-change in growth and performance over next ten years driven by high-quality Vaccines and Specialty Medicines portfolio and late-stage pipeline
23-06-2021
New GSK to positively impact health of >2.5 billion people next 10 years
Viiv healthcare and halozyme enter global collaboration and license agreement or enhanze rug delivery technology to enable development of ultra long acting medicines for hiv
22-06-2021
Halozyme’s technology provides more “shots on goal” to create ultra long-acting HIV medicines with dosing intervals of 3 months or longer.
GSK and vir biotechnology announce continuing progress of the comet clinical development programme for sotrovimab
14-06-2021
GSK now has the leading portfolio of antibodies targeting the CD226 axis - a key target for next-generation immuno-oncology therapies
GSK and iteos therapeutics announce development
14-06-2021
GSK now has the leading portfolio of antibodies targeting the CD226 axis - a key target for next-generation immuno-oncology therapies
GSK to showcase scientific advances and progress in oncology at ASCO and EHA
01-06-2021
GSK will showcase innovative approaches to oncology R&D and cutting-edge science at the upcoming ASCO and EHA meetings.
Sanofi and GSK initiate global Phase 3 clinical efficacy study of COVID-19 vaccine candidate
27-05-2021
Inspiration Bytes Newsletter for Augmentin
Sanofi and GSK initiate global Phase 3 clinical efficacy study of COVID-19 vaccine candidate
27-05-2021
Pending positive Phase 3 outcomes and regulatory reviews, the vaccine could be approved in Q4 2021
gsk-and-vir-biotechnology-announce-sotrovimab-vir-7831-receives-emergency-use-authorization-from-the-us-fda
26-05-2021
Inspiration Bytes Newsletter for Augmentin
GSK and Vir Biotechnology announce sotrovimab (VIR-7831) receives Emergency Use Authorization from the US FDA
26-05-2021
GSK and Vir Biotechnology announce sotrovimab (VIR-7831) receives Emergency Use Authorization from the US FDA
Ema-issues-positive-scientific-opinion-on-gsk-and-vir-biotechnology-s-sotrovimab-for-the-early-treatment-of-covid-19
21-05-2021
Inspiration Bytes Newsletter for Augmentin
EMA issues positive scientific opinion on GSK and Vir Biotechnology’s sotrovimab for the early treatment of COVID-19
21-05-2021
Opinion based on the EMA’s CHMP review of available data on sotrovimab (previously VIR-7831) for the early treatment of COVID-19.
Medicago-and-gsk-announce-positive-interim-phase-2-results-for-adjuvanted-covid-19-vaccine-candidate/
18-05-2021
Inspiration Bytes Newsletter for Augmentin
Medicago and GSK announce positive interim Phase 2 results for adjuvanted COVID-19 vaccine candidate
18-05-2021
Neutralizing antibody responses were ten times higher than in people recovering from COVID-19.
sanofi-and-gsk-covid-19-vaccine-candidate-demonstrates-strong-immune-responses-across-all-adult-age-groups-in-phase-2-trial
17-05-2021
Inspiration Bytes Newsletter for Augmentin
Sanofi and GSK COVID-19 vaccine candidate demonstrates strong immune responses across all adult age groups in Phase 2 trial
17-05-2021
Adjuvanted recombinant COVID-19 vaccine candidate triggered strong neutralizing antibody responses in all adult age groups.
european-commission-approves-benlysta-for-adult-patients-with-active-lupus-nephritis
05-05-2021
Inspiration Bytes Newsletter for Augmentin
European Commission approves Benlysta for adult patients with active lupus nephritis
05-05-2021
First and only biologic approved for both systemic lupus erythematosus and lupus nephritis
Duration of antibiotic therapy for diabetic foot infections
12-08-2020
Diabetic foot infections (DFIs) are associated with a high rate of recurrence or new episodes, prompting many clinicians to prescribe a longer duration of antibiotic therapy than guidelines recommend. This study assessed the relationships between duration and route of antibiotic therapy and risk of recurrence of DFI.* CA-SSTIs: Community-acquired Skin and Soft-tissue Infections.
Duration of surgical antimicrobial prophylaxis by facility type
12-08-2020
Guidelines recommend discontinuation of surgical antimicrobial prophylaxis within 24 h after skin closure. However, dissemination of recommended practices may vary. This study evaluated how facility complexity impacts adherence to guidelines for the timely discontinuation of antimicrobial prophylaxis after outpatient surgery.
Antibiotic guideline adherence vs outcomes
12-08-2020
French guidelines on erysipelas and necrotising fasciitis were published in 2000 and the microbial epidemiology of these infections has not signifi cantly changed since then. This study measured the clinical impact of a guideline-based internal hospital protocol for community-acquired erysipelas and cellulitis in a French tertiary care centre. * CA-SSTIs: Community-acquired Skin and Soft-tissue Infections.
Expert consensus on managing SSTIs in children
12-08-2020
With changing epidemiology of paediatric SSTIs, especially the increase in community-acquired methicillin-resistant Staphylococcus aureus (MRSA) infections, there is a need for an update on management strategies. Hence, an intersociety consensus document has been developed to provide practical recommendations for managing bacterial impetigo, abscess, and cellulitis in children. * CA-SSTIs: Community-acquired Skin and Soft-tissue Infections.
A new SSI risk score for cardiac surgery patients
12-08-2020
The high morbidity and mortality associated with surgical site infection (SSI) in cardiac surgery patients have led to previous attempts to stratify SSI risk using various scoring systems, but their discriminatory abilities are limited. In this study, an analysis of SSI risk factors in cardiac surgery patients was performed and a new SSI risk score developed and assessed.
A preventive bundle to reduce SSIs in gynaecologic oncology
12-08-2020
Surgical site infections (SSIs) are a common and serious problem after gynaecologic oncology surgery. Preventive bundles of interventions to reduce SSI risk have been developed in various surgical subspecialties. This study evaluated the impact of a preventive bundle on SSI rates in gynaecologic oncology surgery.
New publication on the control of Hib disease burden in Europe
03-10-2017
Infanrix hexa’s major contribution to the control of Hib disease burden in Europe
Demo Article about Infanrix
22-05-2017
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua.
Demo Article about Relvar
27-04-2017
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua.
Demo Article about Triumeq
12-04-2017
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua.
Demo Article about Benlysta
28-03-2017
Smoking large numbers of cigarettes causes COPD and that is not a secret. So why do so mych people smoke?
Demo Article about Nucala
18-03-2017
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua.
Demo Article about Avamys
17-03-2017
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua.
Demo Article about Rotarix
16-03-2017
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua.
Demo Article about Infanrix
17-02-2017
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua.
Demo Article about Tivicay
13-02-2017
News on allergy related treatments, atopia etc. Many interesting information on allergies.
Demo Article about Avamys
22-01-2017
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua.
Prostatic urethral angle could predict response to α-blockers in patients with lower urinary tract symptoms
20-01-2017
Research shows that a lower prostatic urethral angle (<33.5°) in patients with LUTS could predict improved response to α-blockers for treatment of nocturia.
Significance of resistive index of prostatic arteries in diagnosis of BPH
20-01-2017
A prospective study in Korea shows the clinical significance of the resistive index of prostatic blood flow for non-invasive diagnosis of BPH with LUTS
Updated guidelines for the management and treatment of patients with benign prostatic hyperplasia
20-01-2017
Updated guidelines for the treatment and management of patients with benign prostatic hyperplasia recommended by researchers from Toronto, Canada.
MRI imaging for characterisation of benign prostatic hyperplasia
20-01-2017
Researchers from Chicago suggest that superior contrast of MRI appears better than ultrasound for classification of types of benign prostatic hyperplasia.
UroLift in the management of BPH
20-01-2017
A review of the UroLift system in the management of benign prostatic hyperplasia, considering the technique, advantages, limitations and concerns.
The relationship between metabolic syndrome, BPH and LUTS
20-01-2017
A new study published in Urology journal has identified that metabolic syndrome is significantly associated with predictors of BPH and the severity of LUTS
Androgen receptor expression in benign and malignant epithelium
20-01-2017
Staining intensity for the androgen receptor was more intense in cases of prostate cancer compared to benign prostatic hyperplasia
Economic analysis of PSA screening and treatment strategies
20-01-2017
Researchers from Seattle suggest strategies to extend PSA screening interval or higher PSA biopsy thresholds could preserve therapeutic benefit and cost.
Laser treatment for benign prostatic hyperplasia: a review
20-01-2017
Laser treatment for BPH rivals the gold-standard TURP with fewer complications. This review examines the most commonly used lasers in BPH surgery
HRQoL after prostatic surgery in patients with BPH in Singapore
20-01-2017
A study of Health-Related Quality of Life (HRQoL), sexual function and psychological well-being found that physical health of BPH patients after prostatic surgery was poor
The role of the endocrine system in BPH development
20-01-2017
A new review article published in Andrology summarises the influence of endocrine factors and inflammation in the pathogenesis of benign prostatic hyperplasisa
Demo Article about Anoro
23-11-2016
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua.
Demo Article about Rotarix
22-11-2016
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua.
Demo Article about Seretide
19-10-2016
Info on new inhalers part 2. Whatever random text. La La Land
Demo Article about Anoro
10-10-2016
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua.
Demo Article about Nucala
04-10-2016
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua...
Demo Article about Relvar
03-10-2016
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua.
Demo Article about Seretide
01-10-2016
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua.
A review of the burden and control of allergic rhinitis
16-06-2016
A recent review discusses the impact of allergic rhinitis on patient perceived health and quality of life, and how control of symptoms can be measured.
Parasitic infection in chronic spontaneous urticaria
25-05-2016
A recent systematic review presents findings on the prevalence of parasitic infection in chronic spontaneous urticaria, and discusses likely pathomechanisms.
Timing of infant vaccinations and allergic disease
25-05-2016
A recent study has linked delayed timing of infant diphtheria-tetanus-acellular pertussis vaccination with a decreased risk of eczema, but not food allergy.
Challenges in seasonal allergic rhinitis
25-05-2016
Non-specific nasal challenge triggers neurogenic inflammation in patients with seasonal allergic rhinitis
Early-life vitamin D decreases risk of allergic rhinitis
15-04-2016
Maternal intake of vitamin D in food, but not in supplements, can reduce the risk of allergic rhinitis in children at school age.
Heterogeneity of allergic rhinitis and impact on asthma
15-04-2016
A patient survey investigated the heterogeneity of allergic rhinitis. Findings were related to the incidence and severity of asthma.
Carbon monoxide increases risk of allergies in children
15-04-2016
Exposure to carbon monoxide increases risk of allergic disease in children.
Homepage
Explore GSKPro for healthcare professionals, offering comprehensive pharmaceutical products, vaccine info and the latest in medical advancement.
Request a contact
Contact us now for any queries about our medicines, vaccines or our services.
Request a medical or scientific contact
Register for the latest news, updates, resources for different therapy areas and basic information about GSK medicines and vaccines.
Rotarix
Rotavirus vaccine, live, oral suspension<br>Vaccines
Trelegy Ellipta
fluticasone furoate/umeclidinium/vilantero <br>Respiratory
Avamys
Fluticasone furoate<br>Respiratory
Avamys
Fluticasone furoate<br>Respiratory
Dovato
Dolutegravir/Lamivudine</br> HIV
Duodart
(dutasteride/tamsulosin HCI) Capsules<br> Urology
Avodart
Dutasteride<br>Urology
Dovato
Dolutegravir/Lamivudine</br> HIV
Dovato
Dolutegravir/Lamivudine</br> HIV
Bexsero
(Meningococcal Group B Vaccine rDNA, component, absorbed)<br>Vaccine
Nucala-MT
Mepolizumab<br> Respiratory
Nucala
Mepolizumab<br> Respiratory
Augmentin
amoxicillin-clavulanate<br>Anti infectives
Rotarix
Rotavirus vaccine, live, oral suspension <br>Vaccines
Seretide Adult
salmeterol xinafoate / fluticasone propionate<br>Respiratory
Benlysta
Belimumab<br> Immunology
Shingrix
(Zoster Vaccine Recombinant, Adjuvanted)
Dovato
Dolutegravir/Lamivudine</br> HIV
Resources
A dedicated page to patient and medical resources spanning GSK’s Therapy Areas and Brands.
Patient resources and samples
A dedicated page to patient and medical resources spanning GSK’s Therapy Areas and Brands
Medical Resources
A dedicated page to patient and medical resources spanning GSK’s Therapy Areas and Brands.
Parent support
This page contains parent support materials
Safety
This page contains information about safety
The STAT Study
The STAT Study
The SALSA Study
The SALSA Study
Efficacy
Efficacy
The GEMINI Studies
The GEMINI Studies
The TANGO Study
The TANGO Study
Real-World Evidence
Real-World Experience
Benlysta (belimumab) Patient Profiles for Healthcare Professionals
Profiles of Benlysta (belimumab) Patients intended for Healthcare Professionals
Podcast
Podcasts of interest to HCPs who treat asthma
Congress highlights from the ICAAC/ICC meeting 2015
Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC) and International Congress of Chemotherapy and Infection (ICC) 2015 meeting highlights.
Congress highlights from ESPID Annual Meeting 2015
Highlights from Annual Meeting of the European Society for Paediatric Infectious Diseases (ESPID 2015) – bacterial infections e-poster walk.
Expression of microRNAs in asthma and allergic rhinitis
Patients with allergic rhinitis and asthma have uniquely expressed subsets of circulating microRNAs, according to a recent study in J Allergy Clin Immunol
Sensitisation to common aeroallergens in Cameroon
A recent study in Cameroon has found a high prevalence of sensitisation to common aeroallergens amongst young adults.
Tyrosine kinase receptor limits type 2 immune response
A recent study in Science has identified a mechanism involving the receptor tyrosine kinase TYRO3, which limits the intensity of type 2 immune responses
Hydrolysed infant formula does not reduce risk of allergies
A recent study commissioned by the UK Food Standards Agency found no clear evidence that hydrolysed cow’s milk formula prevents allergic disease in high-risk infants.
Association of allergy, season of birth and DNA methylation
Patients with allergic rhinitis and asthma have uniquely expressed subsets of circulating microRNAs, according to a recent study in J Allergy Clin Immunol
Highlights from the 26th ECCMID annual meeting 2016
Research highlights from the 26th annual European Congress of Clinical Microbiology and Infectious Diseases in Amsterdam, April 2016.
Congress Updates
Summary of the latest congress updates from different international congresses around the world in Anti infective field.
AASLD
Highlights from the EAU Congress, Munich 2016: understanding personalised medical management for BPH patients at risk of progression and for the elderly.
Congress Updates
Summary of the latest congress updates from different international congresses around the world in Urology field.
News Updates
Summary of the latest News from different sources around the world in Urology field.
Journal Updates
Summary of the latest Journal updates from different international publishers around the world in Urology field.
Prostatic inflammation in REDUCE study participants
A recent analysis has investigated the effect of baseline inflammation on BPH-related parameters in placebo-treated participants of the 4-year REDUCE study
Registration Email Validation
Register now in Health.gsk for Health Care Professionals in Saudi Arabia to access GSK medicines and vaccine information, latest therapy area updates, online and on-demand webinars.
Registration Token
Register now in Health.gsk for Health Care Professionals in Saudi Arabia to access GSK medicines and vaccine information, latest therapy area updates, online and on-demand webinars.
Reset Password Confirmation
Register now in Health.gsk for Health Care Professionals in Saudi Arabia to access GSK medicines and vaccine information, latest therapy area updates, online and on-demand webinars.
Login
Register now in Health.gsk for Health Care Professionals in Saudi Arabia to access GSK medicines and vaccine information, latest therapy area updates, online and on-demand webinars.
Login now in GSK HCP portal
Login for the latest news, updates, resources for different therapy areas and basic information about GSK medicines and vaccines.
Prostatic arterial embolization for BPH
A systematic review of clinical studies evaluates evidence for the use of prostatic arterial embolization in BPH with a discussion of outcomes and complications
Impact of storage and voiding LUTS on quality of life
Structural equation modelling showed that in BPH therapy, improvements in QoL were mainly due to improvement of storage lower urinary tract symptoms
Translational links in MetS, inflammation and LUTS
A systematic review concluded that metabolic syndrome and inflammation could be important contributors to LUTS in men
Metabolic syndrome associated with BPH in UK study
A cross-sectional UK epidemiological study has shown a significant association between benign prostatic hyperplasia and metabolic syndrome.
Journal Updates
Summary of the latest Journal updates from different international publishers around the world in Urology field.
Recommendations for SSI prevention in orthopaedic surgery
Surgical site infections (SSIs) in orthopaedic surgery remain a major problem that is challenging for surgeons and a potential disaster for patients. Although the evidence for preventative strategies continues to grow, many important issues remain unresolved. This review provides a synthesis of recently published guidelines and other relevant evidence.
Terms of Use
GSK UK healthcare professional website terms of use
Cookie Policy
Cookie information for users
Privacy Policy
GSK UK healthcare professional website privacy policy
Lamictal
Lamotrigine<br>Neuroscience
Twinrix
Inactivated hepatitis A and rDNA hepatitis B vaccine (adsorbed)<br>Vaccines
Boostrix
Combined diphtheria, tetanus, acellular pertussis vaccine<br>Vaccines
Anoro Ellipta
Umeclidinium/vilanterol<br> Respiratory
Relvar
Fluticasone furoate/vilanterol<br>Respiratory
Benlysta
Belimumab<br>Immunology
Zinnat
Cefuroxime<br>Anti infective
Infanrix Hexa
Diphtheria (D), tetanus (T), pertussis (acellular, component) (Pa), hepatitis B (rDNA) (HBV), poliomyelitis (inactivated) (IPV) and Haemophilus influenzae type b (Hib) conjugate vaccine (adsorbed)<br>Vaccines
Duodart
0.5 mg dutasteride,0.4 mg tamsulosin hydrochlorid<br>Urology
Triumeq
Dolutegravir-abacavir-lamivudine<br>HIV
Seretide
Salmeterol/fluticasone propionate<br>Respiratory
Synflorix
Pneumococcal polysaccharide conjugate vaccine (adsorbed)<br>Vaccines
Keppra
Levetiracitam<br>Neuroscience
Trelegy
Fluticasone Furoate<br>Respiratory
Seroxat
Paroxetine hydrochloride<br>Neuroscience
Nucala
Mepolizumab<br>Respiratory
Flixotide
Fluticasone propionate<br>Respiratory
Rotarix
Rotavirus vaccine<br>Vaccines
Anoro Ellipta
Umeclidinium/vilanterol<br> Respiratory
Relvar Ellipta
Fluticasone furoate/vilanterol<br> Respiratory
Dovato-mt
Dolutegravir/Lamivudine<br>HIV
Synflorix
Pneumococcal polysaccharide conjugate vaccine (adsorbed)<br> Vaccines
Infanrix Hexa
Diphtheria (D), tetanus (T), pertussis (acellular, component) (Pa), hepatitis B (rDNA) (HBV), poliomyelitis (inactivated) (IPV) and Haemophilus influenzae type b (Hib) conjugate vaccine (adsorbed)<br> Vaccines
Benlysta (belimumab)
Belimumab<br> Immunology
Boostrix
Combined diphtheria, tetanus, acellular pertussis vaccine<br>Vaccines
Menveo
Meningococcal Group A,C,W135 & Y Conjugate Vaccines </br>Vaccines
Duodart
0.5 mg dutasteride,0.4 mg tamsulosin hydrochlorid<br>Urology
keppra_new
Levetiracitam<br> Neuroscience
Augmentin
Amoxicillin trihydrate – Potassium clavulanate<br>Anti-infective
Flixotide
Fluticasone Propionate
Maternal Immunization with Tdap vaccines
Information for health care professionals about the Dosage and administration of Vaccines.
Optimal timing to vaccinate
Information for health care professionals about the Dosage and administration of Vaccines.
Considerations to evaluate Maternal Immunization
Information for health care professionals about the Dosage and administration of Vaccines.
Maternal immunization offers passive immunity to the newborn via transplacental transfer of maternal antibodies
Information for health care professionals about the Dosage and administration of Vaccines.
How does Maternal Immunization Work?
Information for health care professionals about the Dosage and administration of Vaccines.
Maternal Immunization with Tdap vaccines
Information for health care professionals about the Dosage and administration of Vaccines.
Efficacy COPD
Information for healthcare professionals about the clinical efficacy data for Seretide in patients with COPD
Real World Data | BEXSERO (Meningococcal Group B Vaccine)
BEXSERO has demonstrated an impact in reducing cases of meingococcal disease. See real world data and evidence supporting BEXSERO's efficacy with patients.
Dosing and Administration
Dosing and Administration
Patient resources and samples
A dedicated page to patient and medical resources spanning GSK’s Therapy Areas and Brands
Safety
Relvar Ellipta is a once daily inhaled asthma therapy for patients with asthma, delivered through the easy-to-use Ellipta device
Dosage
Anoro Ellipta Dosage Guide, Anoro Inhaler (umeclidinium/vilanterol 62.5/25 micrograms)should be taken as one inhalation once daily by orally inhaled route
Therapeutic index
Therapeutic index
Communication is key
Information for health care professionals about the Dosage and administration of Vaccines.
How to implement Maternal Immunization
Information for health care professionals about the Dosage and administration of Vaccines.
Resources and Tools
Relvar Ellipta is a once daily inhaled asthma therapy for patients with asthma, delivered through the easy-to-use Ellipta device
Lamictal
Lamotrigine<br>Neuroscience
Twinrix
Inactivated hepatitis A and rDNA hepatitis B vaccine (adsorbed)<br> Vaccines
Avamys
Fluticasone furoate<br> Respiratory
Zinnat
Cefuroxime<br> Anti infective
Duodart
Dutasteride-tamsulosin HCl<br> Urology
Triumeq
Dolutegravir-abacavir-lamivudine<br> HIV
Seroxat
Paroxetine hydrochloride<br> Neuroscience
Flixotide Evohaler
Fluticasone propionate<br>Respiratory
Rotarix
Rotavirus vaccine, live, oral suspension<br> Vaccines
Patient Stories | BEXSERO (Meningococcal Group B Vaccine)
Read the true stories of patients and their family who have had experienced meningococcal disease firsthand.
Real World Data | BEXSERO (Meningococcal Group B Vaccine)
BEXSERO has demonstrated an impact in reducing cases of meingococcal disease. See real world data and evidence supporting BEXSERO's efficacy with patients.
Invasive Meningococcal Disease (IMD) | BEXSERO
Learn more about invasive meningococcal disease (IMD) and how this potentially life threatening disease can be prevented through vacination.
boostrix_mt
Tetanus Toxoid, Reduced Diptheria Toxoid and Acellular Pertussis Vaccine, Adsorbed <br> Vaccine
Shingrix
(Zoster Vaccine Recombinant, Adjuvanted)
Keppra_mt
levetiracetam
Bexsero
(Meningococcal Group B Vaccine rDNA, component, absorbed)<br>Vaccines
Heritage in BPH
Heritage in BPH page for BPH
Test for dMMR/MSI-H early
Learn more about MMR/MSI testing to determine eligibility for treatment with immunotherapy in patient with endometrial cancer
Endometrial Cancer
Learn why biomarker driven therapies may redefine the future of treatment for patients with endometrial cancer
Predict with MMR/MSI
Understand why dMMR/MSI-H testing can identify tumours that may respond to immunotheray
Long-term adherence
Long-term adherence page for BPH
Home
Homepage
Havrix
hepatitis A vaccine, inactivated<br>Vaccines
AREXVY- Efficacy
AREXVY is indicated for active immunisation for the prevention of lower respiratory tract disease (LRTD) caused by respiratory syncytial virus in adults 60 years of age and older.
AREXVY- Homepage
AREXVY is indicated for active immunisation for the prevention of lower respiratory tract disease (LRTD) caused by respiratory syncytial virus in adults 60 years of age and older.
AREXVY
AREXVY is indicated for active immunisation for the prevention of lower respiratory tract disease (LRTD) caused by respiratory syncytial virus in adults 60 years of age and older.
AREXVY- Safety
AREXVY is indicated for active immunisation for the prevention of lower respiratory tract disease (LRTD) caused by respiratory syncytial virus in adults 60 years of age and older.
AREXVY- Secondary Analyses
AREXVY is indicated for active immunisation for the prevention of lower respiratory tract disease (LRTD) caused by respiratory syncytial virus in adults 60 years of age and older.
AREXVY- Storage
AREXVY is indicated for active immunisation for the prevention of lower respiratory tract disease (LRTD) caused by respiratory syncytial virus in adults 60 years of age and older.
AREXVY- Q&A
AREXVY is indicated for active immunisation for the prevention of lower respiratory tract disease (LRTD) caused by respiratory syncytial virus in adults 60 years of age and older.
AREXVY- Administration
AREXVY is indicated for active immunisation for the prevention of lower respiratory tract disease (LRTD) caused by respiratory syncytial virus in adults 60 years of age and older.
AREXVY- Vaccine Design
AREXVY is indicated for active immunisation for the prevention of lower respiratory tract disease (LRTD) caused by respiratory syncytial virus in adults 60 years of age and older.
Home
SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted) product information and resources to support HCPs in their daily practice.
Recommendation
SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted) is recommended by the CDC for the prevention of shingles (herpes zoster) and related complications for immunocompetent adults aged ≥50 years.
Efficacy Against Shingles
SHINGRIX delivered >90% efficacy against shingles in all age segments ≥50 years old
Scientific Rationale
Recommend the shingles vaccine specifically formulated to address age-related decline in immunity
Safety
The safety of SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted) was extensively studied in 2 large phase 3 clinical trials
Patient Profiles
Is SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted) right for your patients? Nearly everyone ≥50 years old needs shingles protection
Resources
Resources for HCPs and patients about SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)
PHN and Sustained Efficacy
SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted) nearly eliminates the risk of developing PHN by preventing shingles
Video Center
Watch on-demand videos about SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)
Unmet Need
Patients ≥50 years old are at risk for shingles, no matter how healthy they may feel
SHINGRIX in your Practice
Read about SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted) dosing and administration details, information to share with patients, and guidance for series completion
IC patient profile
IC patient profile
AREXVY
Vaccines<br> Respiratory Syncytial Virus (Vaccine Recombinant Adjuvanted)
Bexsero
(Meningococcal Group B Vaccine rDNA, component, absorbed) </br> Vaccine
Zejula
(niraparib) Tablets </br> Oncology
Invasive Meningococcal Disease (IMD) | BEXSERO
Learn more about invasive meningococcal disease (IMD) and how this potentially life threatening disease can be prevented through vacination.
Real World Data | BEXSERO (Meningococcal Group B Vaccine)
BEXSERO has demonstrated an impact in reducing cases of meingococcal disease. See real world data and evidence supporting BEXSERO's efficacy with patients.
Patient Stories | BEXSERO (Meningococcal Group B Vaccine)
Read the true stories of patients and their family who have had experienced meningococcal disease firsthand.
Home
(Meningococcal Group B Vaccine rDNA, component, absorbed)<br>Vaccine
Safety
Safety of Benlysta Singapore
Efficacy
Efficacy of Benlysta
MOA
MOA
Home
Belimumab<br> Immunology
The STAT Study
The STAT Study
Efficacy
Efficacy
The GEMINI Studies
The GEMINI Studies
The TANGO Study
The TANGO Study
The SALSA Study
The SALSA Study
Real-World Evidence
Real-World Experience
Patient Experience
Discover the patient experience, and learn more about monitoring and management recommendations with ZEJULA (niraparib)
Resources overview
Access ZEJULA (niraparib) resources and support for clinics, healthcare professionals and patients
Expert perspectives
Access ZEJULA (niraparib) resources and support for clinics, healthcare professionals and patients
ZEJULA Overview
Explore ZEJULA (niraparib), including Phase 3 trial results and long-term efficacy and safety data
Tablet formulation
Access ZEJULA (niraparib) resources and support for clinics, healthcare professionals and patients
Patient support kit
Access ZEJULA (niraparib) resources and support for clinics, healthcare professionals and patients
Home
Learn more about ZEJULA (niraparib), a PARP inhibitor for the maintenance treatment of advanced ovarian cancer
Resources
Access ZEJULA (niraparib) resources and support for clinics, healthcare professionals and patients
Study design
Explore ZEJULA (niraparib), including Phase 3 trial results and long-term efficacy and safety data
Products
Explore GSK's extensive products portfolio, access detailed information on vaccines, respiratory treatments, and more. Stay informed with the latest updates.
Register now in GSK HCP portal
Sign up for GSKPro to access exclusive resources and tools for healthcare professionals. Create your account today for insights, product information, and more
Contact us now in GSK HCP portal
Contact GSKPro for support and inquiries. Our team is here to assist healthcare professionals with pharmaceutical products, clinical resources, and more.
Therapy areas
Access the latest updates and guidelines on GSK's therapy areas, including Respiratory, Vaccines, Anti-Infectives, Neuroscience, BPH, HIV and immunology
Susceptibility
Augmentin Susceptibility
Home
amoxicillin-clavulanate<br>Anti infectives
Efficacy
Augmentin Efficacy
Guidelines
Augmentin Guidelines
Disease Information
Overview on the BPH diagnosis and management.
Patient Support
HCPs can access materials and downloads which will be useful to their patient and practice
Advice for pharmacists on allergic rhinitis
A recent article in Pharmacy Times highlighted the guidance pharmacists can offer to patients on the treatment and management of allergic rhinitis.
News Updates
Summary of the latest News from different sources around the world in Urology field.
Expert views
Watch experts’ videos in the Urology field from different regional and global professors.
Journal Updates
Summary of the latest Journal updates from different international publishers around the world in Dermatology field.
HIV
We offer a wide range of HIV medicines to help more patients with HIV.
Anti infective
A quick look at Anti-Infectives.
Webcasts and Videos
HCPs can learn from experts in the vaccines field by watching on demand webcasts and videos.
Adverse drug reactions to second-generation antihistamines
A study of adverse drug reactions to second-generation antihistamines in children in the Netherlands found these may be more common than previously thought
Expert views
Watch experts’ videos in the Dermatology field from different regional and global professors.
Journal Updates
Summary of the latest Journal updates from different international publishers around the world in Allergy field.
Hepatitis
GSK offers a range of Hepatitis medicines for different types of surgeries and patients.
Highlights from the American Academy of Allergy, Asthma & Immunology Annual Meeting
Summary of the latest congress updates from different international congresses around the world in Allergy field.
European Association of Urology Congress 2016 highlights
Highlights from the EAU Congress, Munich 2016: understanding personalised medical management for BPH patients at risk of progression and for the elderly.
Focus on RTI, highlights from ESPID 2016
Highlights of research on respiratory tract infections presented at the 2016 European Society for Paediatric Infectious Diseases meeting in Brighton, UK.
How To Order
Find out how HCPs can order GSK vaccines online from vaccines.co.uk.
Congress Updates
Summary of the latest congress updates from different international congresses around the world in Urology field.
Prostate size as predictor of lower urinary tract symptoms
A post-hoc analysis of the REDUCE trial found that men with increased prostate size are at higher risk of incident lower urinary tract symptoms
News Updates
Summary of the latest News from different sources around the world in Allergy field.
Innovations in BPH management
A review of recent technological innovations with potential clinical impact on the treatment of benign prostatic hyperplasia.
Heritage
HCPs can learn about GSK’s history and legacy in the vaccines business.
Corticosteroid prescriptions for chronic urticaria
A recent study revealed corticosteroid prescriptions for chronic spontaneous urticaria decreased following an evaluation by an allergy/immunology specialist.
Monotherapies for BPH remain prevalent
Benign prostatic hyperplasia is commonly treated by monotherapy despite evidence from clinical trials indicating that combination therapy is more effective.
Prevalence, comorbidities and treatment of allergic rhinitis
The prevalence, associated comorbidities, and treatment of allergic rhinitis have been investigated in a recent study published in Allergy.
LUTS link to metabolic disorders
Summary of proceedings from ICI-RS 2014 highlighting potential links between lower urinary tract symptoms and metabolic disorders.
Congress Updates
Summary of the latest congress updates from different international congresses around the world in Allergy field.
Expert views
Watch experts’ videos in the Allergy field from different regional and global professors.
Highlights of the 9th WSPID congress
The 9th WSPID congress was held from 18–21 November 2015 in Brazil, with a focus on the treatment and prevention of paediatric infectious diseases.
GSK Allergy medicines
GSK offers a wide range of Allergy medicines for different type of patients
Dermatology
Therapy area information, latest congress, journals updates and news in Dermatology field from different sources complemented by expert videos.
Dermatology Portfolio
GSK offers a wide range of Dermatological medicines for different type of patients
Disease Information
Overview on the different dermatological diseases, management guidlines and different patient presentations.
Vaccine Slides
HCPs can access and download a range of informative slides about vaccines and the vaccination process.
Vaccines Overview Page
GSK UK information about our vaccines portfolio, as well as resources and latest news.
Useful HCP Resources
HCPs can access useful resources and downloads relating to GSK vaccines, travel health and vaccination in general.
Risk of major cardiac adverse events in males with LUTS
A systematic literature search and meta-analysis has found the risk of major cardiac adverse events is increased in males with LUTS
Anaesthesia
GSK offers a wide range of Anaesthesia medicines for different types of surgeries and patients.
Sleep quality in people with LUTS and nocturia
A cross-sectional study in China has investigated the effect of nocturia on sleep quality and daytime functioning, specifically in people with LUTS
Congress Updates
Summary of the latest congress updates from different international congresses around the world in Dermatology field.
Seasonal allergies and climate change
A Focus article published in Environmental Health Perspectives summarises current knowledge on climate-induced changes in allergic symptoms
News Updates
Summary of the latest News from different sources around the world in Dermatology field.
Allergy
Therapy area information, latest congress, journals updates and news in Allergy field from different sources complemented by expert videos.
Our Portfolio
Healthcare professionals can see the range of vaccines in GSK’s portfolio.
Urology
Therapy area information, latest congress, journals updates and news in Urology field from different sources complemented by expert videos
No results. Why not try:
- Checking the spelling of the search term
- Trying a different search term
- Resetting or revising the filter settings (if you used filters to do this search)
Show more
